CLINICAL ROLE -
Practice-Changing Data Revealed for Premenopausal HR+ Breast Cancer
Findings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.
Read More